Selected article for: "cc NC ND International license and severity score"

Author: Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Zhibing Lu; Stella K Kang; David Fenyo; Timothy Alcorn; Isaac P Dapkins; Iman Sharif; Deniz Vurmaz; Sayli S Modak; Kritika Srinivasan; Shruti Warhadpande; Ravi Shrivastav; John T McDevitt
Title: Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19
  • Document date: 2020_4_22
  • ID: h4lsvgxo_24
    Snippet: This study involves the development of a COVID-19 Severity Score using similar methods as described previously. 22 Biomarker data from 160 hospitalized COVID-19 patients were derived from a recent study in Wuhan, China. 14 Patients were assigned to two outcomes: patients who . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: This study involves the development of a COVID-19 Severity Score using similar methods as described previously. 22 Biomarker data from 160 hospitalized COVID-19 patients were derived from a recent study in Wuhan, China. 14 Patients were assigned to two outcomes: patients who . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and recent study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • China Wuhan recent study and recent study: 1, 2, 3, 4, 5
    • International license and patient outcome: 1
    • International license and recent study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • patient outcome and recent study: 1, 2, 3
    • previously describe and recent study: 1